Nausea. Diarrhea. Stomach cramps.
Those are the Ozempic side effects that make the package insert. They’re real, and for a lot of people they’re manageable. But beyond the standard warnings, a separate category of Ozempic side effects most people don’t know about has been emerging. Less discussed, in some cases irreversible, and in almost no cases disclosed upfront.
These are the ones worth knowing about before you start.
Does Ozempic Affect Your Mood and Ability to Feel Pleasure?
Some patients describe it as a persistent “blah.” Not quite depression, but a flattening of everyday joy. The excitement they used to feel about a good meal, a night out, intimacy with a partner, or a favorite hobby just isn’t there the same way anymore.
Clinicians are calling it “Ozempic personality.” The medical term is anhedonia: a reduced capacity to experience pleasure.
GLP-1 drugs work in part by influencing dopamine signaling in the brain’s reward center. Dopamine drives motivation, anticipation, and pleasure. So when these medications dial down food cravings, they may also dial down other dopamine-driven responses. The same system that made overeating feel compulsive is the one that makes a sunset worth stopping for. As one obesity researcher put it, “GLP-1s tone down regions of the brain associated with pleasure.”
What Does Ozempic Anhedonia Actually Feel Like?
One patient described the experience this way: she would look at a gorgeous birthday cake or walk outside to a pink-and-purple sunset, but not really enjoy them. Not depression, she said. Just “meh.” Similarly, doctors say reports of emotional blunting are appearing with enough frequency that physicians are now compiling case studies to better characterize the phenomenon.
Worth noting: many patients report improved mental health on GLP-1s, including less shame around food and better self-esteem. However, for those who experience emotional dulling, it often catches them off guard because no one mentioned it was possible. Anhedonia is not currently listed as an adverse drug reaction or warning for Ozempic, Wegovy, or Mounjaro, and clinical trials did not study it.
In Chinese medicine, this pattern resonates with Liver Qi Stagnation and Heart Blood deficiency. The Liver governs the smooth flow of emotion and motivation. The Heart houses the Shen, or spirit, and carries responsibility for our capacity for joy and mental clarity. When either system is dysregulated, patients feel emotionally flat or disconnected from what used to bring meaning. Because acupuncture and herbal medicine address these patterns directly, we don’t have to wait and see whether they self-resolve.
Image by magnific
What Is “Ozempic Face”?
Patients starting semaglutide often focus on the number on the scale. What they don’t anticipate is looking in the mirror and seeing an older version of themselves staring back.
“Ozempic face” describes the facial volume loss and skin sagging that can accompany rapid weight loss on GLP-1 medications. Fat in the face acts as a natural filler, supporting cheek structure and giving skin its fullness. When weight drops quickly, facial fat disappears alongside body fat. As a result, the changes can include hollowed cheeks, more prominent bone structure, deeper nasolabial folds, and skin that no longer has the underlying volume to look taut.
To be clear: this is not the medication acting directly on facial tissue. Instead, it is a consequence of rapid fat loss that can happen with any significant weight loss. What makes it notable with semaglutide is the speed. The medication’s effectiveness at accelerating fat loss amplifies how quickly the facial change appears, and skin doesn’t always adapt fast enough. Additionally, patients over 40 tend to notice it more acutely, given natural collagen decline.
In Chinese medicine, rapid weight loss is recognized as a drain on Essence (Jing) and Blood, the foundational resources that nourish skin, hair, and tissue. A functional medicine lens adds another dimension: protein intake, collagen synthesis, and micronutrients like zinc, vitamin C, and silica are all critical to how skin adapts during fat loss. For patients on GLP-1 medications, therefore, monitoring nutrition and actively supporting collagen production can make a meaningful difference in how the body handles the transition.
What Is “Ozempic Teeth”?
Dentists across the country are seeing a pattern: patients with no prior history of dental problems presenting with cavities, enamel erosion, gum sensitivity, and in some cases tooth loss, months after starting a GLP-1 medication. They’ve started calling it “Ozempic teeth.”
Like Ozempic face, the drug isn’t attacking teeth directly. Instead, it triggers a cascade of secondary effects that change the chemistry of the mouth. A 2024 pharmacovigilance analysis identified dry mouth, salivary gland dysfunction, and oral infections as adverse events reported with semaglutide use, giving the pattern a legitimate clinical basis beyond social media.
Three main pathways are at play.
Dry mouth. Semaglutide affects secretion throughout the GI tract, including the salivary glands. Saliva is your mouth’s defense system. It neutralizes acid, remineralizes enamel, and clears bacteria. Less saliva means faster decay. Furthermore, many patients drink less water because they feel less thirsty, compounding the problem.
Nausea and vomiting. A significant percentage of users experience GI side effects, especially early in treatment or with dose increases. Consequently, stomach acid from frequent vomiting erodes enamel aggressively. Enamel loss is not reversible.
Nutritional gaps. GLP-1 medications suppress appetite substantially. For some patients, this crosses into nutrient deficiency, particularly calcium and vitamin D, both of which are foundational to bone density, gum integrity, and tooth strength.
Unlike most GLP-1 side effects, dental damage may not reverse after stopping the medication. In Chinese medicine, the kidneys govern bone, and kidney deficiency patterns frequently manifest in dental fragility and receding gums. From a functional medicine standpoint, nutritional status, hydration, and any underlying deficiencies are part of the picture. These are all things we assess as part of a comprehensive intake.
Can Ozempic Affect Your Eyesight?
This is the Ozempic side effect that has drawn the most recent regulatory attention, and it warrants a direct conversation with your prescriber before starting.
The condition at the center of the concern is called non-arteritic anterior ischemic optic neuropathy, or NAION. In plain terms, it’s a stroke of the optic nerve. Blood flow to the front portion of the optic nerve suddenly reduces, causing immediate, painless vision loss in one eye. The vision loss is typically permanent, and no effective treatment currently exists to restore it.
A 2024 study published in JAMA Ophthalmology found that patients with type 2 diabetes taking semaglutide were significantly more likely to develop NAION than patients on other diabetes medications. In May 2025, the EMA’s Pharmacovigilance Risk Assessment Committee formally concluded that NAION is a “very rare” side effect of semaglutide, potentially affecting up to 1 in 10,000 people, and mandated label updates for Ozempic, Rybelsus, and Wegovy accordingly. In June 2025, the World Health Organization issued a global alert confirming the finding. If NAION is confirmed in a patient taking semaglutide, current guidance calls for stopping the medication.
Who Is at Highest Risk for Ozempic Vision Loss?
The absolute risk is low. However, people at elevated risk deserve to know they’re at elevated risk. That includes patients with type 2 diabetes, high blood pressure, long-standing vascular disease, sleep apnea, older age, or a small, crowded optic disc anatomy. Additionally, rapid blood pressure or blood sugar changes from starting semaglutide may play a role in susceptible individuals.
If you experience sudden painless vision loss in one eye, or a shadow or blank area in your visual field while on a GLP-1 medication, seek emergency eye care immediately.
In Chinese medicine, the eyes are nourished by Liver Blood and Kidney Essence. Because of this, microcirculation support and vascular health are areas where acupuncture and targeted supplementation can play a meaningful complementary role, particularly for patients with pre-existing risk factors managing complex metabolic conditions.
Before You Start, Consider What You Haven’t Been Offered
The conditions GLP-1 medications are prescribed for, including blood sugar dysregulation, metabolic syndrome, and weight gain, don’t develop overnight. Instead, they build over years, often from a combination of chronic stress, sleep disruption, hormonal imbalance, gut dysfunction, and nutrient depletion. These are root causes. A weekly injection addresses none of them.
We understand why people reach for fast solutions. The cultural pressure around weight is real and relentless. Because GLP-1 marketing is built on rapid results and before-and-after images, urgency drives every message. But the same urgency that makes a quick fix appealing makes it easy to minimize what you’re trading away.
Permanent vision loss. Irreversible dental damage. Emotional blunting. These are not remote theoretical risks. They are outcomes that patients are experiencing and reporting right now.
The body didn’t arrive at imbalance quickly. As a result, lasting correction takes time. That is not a weakness of integrative medicine. It is how genuine physiological change works. And for most people, the timeline is far shorter than the years it took to develop the problem.
What the ATH Approach Actually Looks Like
Acupuncture, functional medicine testing, herbal medicine, and targeted nutritional support can address blood sugar regulation, metabolic function, inflammatory load, and the hormonal and digestive patterns that drive weight gain, without the Ozempic side effects described above. For patients already on semaglutide who aren’t ready to stop, these same tools address what the medication doesn’t cover.
It starts with a consultation. We want to understand what’s happening in your body, what you’ve already tried, and what you’re actually trying to change. From there, if comprehensive testing is warranted, we run functional bloodwork through Evexia Diagnostics (processed through LabCorp), going well beyond a standard panel. Specifically, we look at blood sugar regulation, thyroid function, inflammatory markers, hormone balance, nutrient status, and more.
For patients where gut health is central to the picture, the GI-MAP stool test gives us a detailed view of the microbiome, digestive function, pathogens, and gut inflammation that standard labs don’t assess. This matters because the conditions most often driving people toward GLP-1 prescriptions, including insulin resistance, weight gain, and metabolic dysfunction, frequently have roots in gut dysbiosis, chronic inflammation, nutrient depletion, and hormonal imbalance. Testing tells us exactly what’s driving your specific pattern.
From that foundation, we build a customized protocol. Acupuncture, Chinese herbal medicine, targeted supplementation, and dietary guidance are tailored to your results, not a generic weight loss plan. Every protocol reflects what’s actually happening in your body.
If you’ve been told a GLP-1 medication is your best option, we’d encourage you to find out what a thorough integrative assessment might reveal first. You may have more options than you’ve been offered.
Ready to explore a root-cause approach to metabolic health? Schedule a consultation with Dr. Bryn and let’s look at the full picture.
Want to learn more about our functional medicine testing and services?
Questions? Contact us or check out our FAQ!
This post is for educational purposes only and does not constitute medical advice. Always consult with your prescribing physician before making any changes to your medication.
